| PE17.02 | Recombinant human (rh)ERAPs anti-HIV effect relies on activation of innate immunity | E-poster | Innate and trained immunity |
| PE11.01 | Rates of Undiagnosed HIV Infection Among Racial/Ethnic Subgroups in a Large Nationwide Cohort Study of Sexual Minority Men in the U.S.: Evidence for Reframing from Disparities to Inequities | E-poster | Epidemiology of HIV |
| OA06.02 | Randomized, placebo-controlled trial of safety, pharmacokinetics, and pharmacodynamics of 90-day intravaginal rings (IVRs) releasing tenofovir (TFV) with and without levonorgestrel (LNG) among women in Western Kenya | Oral Abstract Session | Delivery technologies: novel approaches, formulation and multi-purpose |
| OA06.03 | Randomized, Placebo Controlled Phase I Trial of Safety, Pharmacokinetics, Pharmacodynamics and Acceptability of a Multipurpose Prevention Vaginal Ring Containing Tenofovir and Levonorgestrel | Oral Abstract Session | Clinical trial results |
| PE01.05 | Race, Minority Stress and HIV Prevention: The Impact of Intersectional Stigma on PrEP Engagement Among Black Men Who Have Sex With Men | E-poster | Behavioural and social science research |
| OA22.01 | R5 tropic HIV-1 is preferentially translocated of across genital mucosa while X4 tropic HIV-1 is selectively sequestered in genital epithelial cells and activates type I IFN signaling | Oral Abstract Session | Transmission of HIV |
| PU26.01 | Quality and turnaround times of PMTCT viral load monitoring under Option B+ in six South African districts with high antenatal HIV burden | Publication Only | Testing: technology, coverage, viral load, point of care and CD4 count |
| OA02.03 | Progress toward HIV elimination goals: trends in and projections of treatment as prevention strategy in 38 African countries | Oral Abstract Session | Treatment as prevention |
| PU29.01 | Programming for female sex workers during COVID-19 pandemic: experiences from Bar Hostess Empowerment and Support Program, Nairobi Kenya | Publication Only | Treatment as prevention |
| OA02.01 | Profiling the HIV epidemic with recency of infection instead of recency of diagnosis: 2 years of experience in North Carolina, USA | Oral Abstract Session | Epidemiology of HIV |